The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Prentice, RL. (2006). Research opportunities and needs in the study of dietary modification and cancer risk reduction: The role of biomarkers. Journal of Nutrition, 136, 2668S-2670S.
Shumaker, S., Legault, C., Rapp, S., Thal, L., Wallace, R., Ockene, J., Hendrix, S., Jones, B., III, Assaf, A., Jackson, N., Kotchen, J., Wassertheil-Smoller, S., and Wactawski-Wende, J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in post-menopausal women. The Women’s Health Initiative Memory Study: A Randomized Controlled Trial. Journal of the American Medical Association, 289, 2652-2662.
Trull, A., Demers, L., Holt, D., Johnston, A., Tredger, M., and Price, C.P. (2002). Biomarkers ofdisease: An evidence-based approach. Cambridge, England: Cambridge University Press.
Tworoger, S., and Hankinson, S. (2006). Use of biomarkers in epidemiological studies: Minimizing the influence of measurement error in the study design and analysis. CancerCauses and Control, 17, 889-899.
Wild, C., Andersson, C., O’Brien, N., Wilson, L., and Woods, J. (2001). A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. BritishJournal of Nutrition, 86, (Suppl.)1, S37-S53.
Women’s Health Initiative Steering Committee. (2004). Effects of conjugated equine estrogen in post-menopausal women with hysterectomy. Journal of the American Medical Association, 291, 1701-1712.
Women’s Health Initiative Study Group. (1998). Design of the Women’s Health Initiative clinical trial and observational study. Controlled Clinical Trials, 19, 61-109.
Writing Group for the Women’s Health Initiative. (2002). Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results from the Women’s Health Initiative. Journal of the American Medical Association, 288, 321-333.